Karl T. Beer

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

Michael Henke, Roland Laszig, Christian Rübe et al. · The Lancet · 2003 · 1.2K citations

Neck Cancer Patients, Radiation Therapy, Medicine +9

Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

Daniel M. Aebersold, Philipp Burri, Karl T. Beer et al. · PubMed · 2001 · 606 citations

Tumor Biology, Hypoxia-inducible Factor, Squamous Cell Cancer +15

Human papillomavirus positive squamous cell carcinoma of the oropharynx

Katja Lindel, Karl T. Beer, Jean A. Laissue et al. · Cancer · 2001 · 455 citations

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

P Huguenin, Karl T. Beer, Abdelkarim S. Allal et al. · Journal of Clinical Oncology · 2004 · 252 citations · Full text

Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation

Daniel M. Aebersold, Attila Kollár, Karl T. Beer et al. · International Journal of Cancer · 2001 · 86 citations · Full text